Compare AstraZeneca plc (AZN) vs FMC Corp (FMC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AstraZeneca plc vs FMC Corp — how do they compare? AstraZeneca plc trades at $166.95 (market cap $258.17B), while FMC Corp trades at $10.75 (market cap $1.37B). The key difference: AstraZeneca plc is far larger — about 188.4× FMC Corp's market cap, and FMC Corp pays the higher dividend (2.93%). Which is the better fit depends on your goals.
| AZN | FMC | |
|---|---|---|
Market Cap | $258.17B | $1.37B |
Sector | Health | Basic Materials |
52-Week High | $209.48 | $43.90 |
52-Week Low | $137.44 | $10.72 |
Enterprise Value | $284.41B | $5.51B |
Dividend Yield | 1.87% | 2.93% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AstraZeneca plc
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, and immunology. The majority of sales come from international markets with the United States representing close to one third of its sales.
Read more on AZN →About FMC Corp
FMC is a pure-play crop chemical company. The company has diversified its sales to create a balanced crop chemical portfolio across geographies and crop exposure. Through acquisitions, FMC is now one of the five largest patented crop chemical companies and will continue to develop new products, with a focus on biologicals, through its research and development pipeline.
Read more on FMC →
